November 8, 2023 Nordic Capital acquires majority share in IntegriChain, the only fully integrated platform for pharma commercialization and market access Nordic Capital has signed an agreement to acquire a majority share in IntegriChain. Nordic Capital is acquiring the majority stake from Accel-KKR, a global software private equity firm, which first invested in IntegriChain in 2016.
November 7, 2023 IntegriChain Presents The Tina Patel Shining Light Award to Patrick Townsend of Vertex Pharmaceuticals IntegriChain presents customer awards to Patrick Townsend of Vertex as well as Johnson & Johnson Innovative Medicine, Alexion Pharmaceuticals, and Tarsus Pharmaceuticals.
October 10, 2023 Key Pharma Commercialization Experts to Converge at Access Insights Conference 2023 The Access Insights Conference 2023 is sponsored by Asembia, AssistRx, BRG, ConnectiveRx, EntityRisk, Pharmaceutical Commerce, Phil, Redi.Health, and Turquoise Health.
September 12, 2023 IntegriChain Expert to Speak on the Inflation Reduction Act at MDRP Summit Pharmaceutical pricing and regulatory expert and Vice President of Operational Consulting Jeff Baab will speak on the impact of the Inflation Reduction Act (IRA) at the Medicaid Drug Rebate Reporting Summit 2023.
June 27, 2023 Blue Fin Group, an IntegriChain Company, Promotes Jason Bogroff to Partner Blue Fin Group promotes seasoned industry advisor Jason Bogroff to partner. In his new role, Bogroff will have direct client responsibility and will lead the firm’s Data Strategy area of focus.
June 22, 2023 IntegriChain and Verato Partner on Securing Patient Privacy Data IntegriChain and Verato announced a technology partnership in which IntegriChain utilize Verato’s healthcare master data management (hMDM) solution to create a new ICyte Secure PHI Vault for securing protected health information (PHI) and personal identifiable information (PII).
June 15, 2023 IntegriChain and Knipper Team Up to Support Emerging Pharmaceutical Manufacturers Preparing for Commercialization IntegriChain and Knipper Health announced a non-exclusive joint initiative to support emerging manufacturers launching new products that need comprehensive 3PL services, order-to-cash, government pricing, and claims adjudication support.
May 9, 2023 IntegriChain Expert to Speak on the Inflation Reduction Act at Informa’s Medicaid & Government Pricing Congress IntegriChain pharmaceutical pricing and regulatory expert and Vice President of Operational Consulting Jeff Baab will speak on the impact of the Inflation Reduction Act (IRA) at Informa’s Medicaid & Government Pricing Congress.
April 18, 2023 IntegriChain and Second Sight Solutions to Team up on 340B Issue Prevention for Pharma Manufacturers IntegriChain and Second Sight Solutions announced plans for a new joint initiative for 340B Drug Pricing Program duplicate discount prevention. The initiative, when implemented, will be capable of integrating 340B claims submitted by covered entities and contract pharmacies to Second Sight’s 340B ESP™ platform into IntegriChain’s ICyte® Script Management solution, which retrieves, validates, and reconciles all claims at scale.
